Tetra Bio-Pharma Announces Initiation of Coverage by Paradigm Capital

13 August, 2018 ORLEANS, Ontario, Aug. 13, 2018 – Tetra Bio-Pharma Inc., a leader in cannabinoid-based drug discovery and development (TSX VENTURE:TBP) (OTCQB:TBPMF), today announced that Paradigm Capital, an independent investment banking and advisory group, based in Toronto, has initiated research coverage of Tetra Bio-Pharma. Today’s initiation of coverage by Paradigm represents another step forward